Preferred Label : Neuronopathy, distal hereditary motor, autosomal dominant 6;
Symbol : HMND6;
CISMeF acronym : DHMN2D; HMN2D;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Neuronopathy, distal hereditary motor, harding type iid; Spinal muscular atrophy, distal, autosomal dominant, calf-predominant; DHMN2D; Hmn iid; Neuropathy, distal hereditary motor, harding type iid; HMN2D;
Description : Distal hereditary motor neuronopathy type IID is an autosomal dominant neurologic
disorder characterized by onset of slowly progressive distal lower limb weakness and
atrophy between the second and fourth decades of life. Weakness usually begins in
the calf muscles and later involves more proximal muscles. The severity is variable,
and some patients have difficulty walking or running. Most also have upper limb involvement,
particularly of the triceps and intrinsic hand muscles. Some patients may lose independent
ambulation later in the disease course. Sensory impairment is typically not present,
and cognition and bulbar function are normal (summary by Sumner et al., 2013). For
a general phenotypic description and a discussion of genetic heterogeneity of distal
HMN (dHMN), see HMN type I (HMN1; 182960).;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the F-box only protein 38 gene (FBXO38, 608533.0001);
Prefixed ID : #615575;
Origin ID : 615575;
UMLS CUI : C3888271;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
Validated automatic mappings to NTBT